Circ_0074026 Sponges miR-127-5p to Upregulate RBP7 and Promotes Hepatocellular Carcinoma Progression
This study demonstrates that circ_0074026 promotes hepatocellular carcinoma progression by acting as a molecular sponge for miR-127-5p, thereby upregulating RBP7 to enhance cell proliferation, migration, invasion, and epithelial–mesenchymal transition while inhibiting apoptosis.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every human cell, a complex network of molecular instructions dictates how the body grows, repairs itself, and fights disease. Among the many types of molecules that carry out these instructions, a specific group called circular RNAs has recently captured the attention of scientists. Unlike the more familiar linear strands of genetic material, these circular molecules form a closed loop, a shape that makes them remarkably stable and resistant to the cellular enzymes that usually break down genetic messages. In recent years, researchers have discovered that these loops are not just passive debris but active players in the development of cancer. They can act as sponges, soaking up other regulatory molecules that normally keep cell growth in check, thereby allowing tumors to grow unchecked. Understanding how these loops function offers a new window into the mechanics of disease and a potential path toward better ways to detect and treat cancer.
In a study focused on liver cancer, researchers from Wenzhou Medical University in China have uncovered a specific chain of events driven by one of these circular molecules. The team investigated a circular RNA known as circ_0074026, which had previously been linked to a different type of brain tumor but whose role in liver cancer remained a mystery. By examining tissue samples from patients with hepatocellular carcinoma, the most common form of liver cancer, the scientists found that this circular molecule was present in much higher amounts in cancerous tissue than in healthy liver tissue. The levels were so high that the molecule appeared to be a reliable marker for the disease, distinguishing patients with liver cancer from healthy individuals with a high degree of accuracy. Furthermore, patients whose tumors contained high levels of this molecule tended to have more aggressive disease, larger tumors, and shorter survival times, suggesting that the molecule is not just a bystander but a driver of the cancer's progression.
To understand how this molecule causes harm, the researchers turned to cell cultures and animal models. They found that when they reduced the amount of circ_0074026 in liver cancer cells, the cells stopped growing as quickly, struggled to move and invade other tissues, and were more likely to die off naturally. This indicated that the molecule was actively fueling the cancer's ability to spread and survive. The study then traced the mechanism behind this behavior, revealing a three-part interaction. The circular RNA was found to bind tightly to a smaller molecule called miR-127-5p, which normally acts as a brake on cancer growth by suppressing a specific protein. By soaking up this braking molecule, the circular RNA effectively removed the brakes. This allowed another molecule, a protein called RBP7, to build up to high levels. The researchers confirmed that high levels of RBP7 were also found in patient tumors and that this protein was essential for the cancer cells to grow and spread. When the team blocked RBP7 or restored the braking molecule, the cancer-fueling effects of the circular RNA disappeared.
The implications of these findings extend beyond the laboratory. Because the circular molecule is stable and can be detected in the blood, the researchers tested its potential as a diagnostic tool. They analyzed serum samples from patients and found that measuring the levels of this molecule could effectively identify those with liver cancer, performing well even in cases where standard markers might fail. While the study was conducted in a single medical center and requires further validation in larger groups of people, the results point to a clear and specific pathway: the circular RNA circ_0074026 promotes liver cancer by neutralizing a protective microRNA, which in turn allows a harmful protein to drive tumor growth. This discovery offers a new target for future therapies and a potential new method for early detection, providing a clearer picture of the molecular machinery that powers one of the world's most challenging cancers.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.